ГоловнаArchive of numbers2022Volume 30, issue 3 (112)Clinical-psychopathological, genealogical and genetic regularities of formation of recurrent depressive disorders
Title of the article Clinical-psychopathological, genealogical and genetic regularities of formation of recurrent depressive disorders
Authors Maruta Natalia
Atramentova Lyubov
Utevska Olha
Panko Tamara
Semikina Olena
Cheredniakova Olena
In the section DIAGNOSTICS AND THERAPY OF NEUROLOGICAL, MENTAL AND NARCOLOGICAL DISORDERS
Year 2022 Issue Volume 30, issue 3 (112) Pages 105-114
Type of article Scientific article Index UDK 616.8-008.64:575.191 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V30-is3-2022-92

 The purpose of the research: analysis of clinical-psychopathological, genealogical and genetic regulari- ties of the formation of recurrent depressive disorders (RDD) for the improvement of diagnosis and therapy. 175 patients with RDD were examined (main group), who underwent an inpatient course of treatment in the department of borderline psychiatry of the Department of Borderline Psychiatry of the State Institute of Internal Medicine of the National Academy of Medical Sciences of Ukraine, the comparison group included 46 people without mental disorders. The diagnosis of RDD was established according to the criteria of ICD-10. As a result of the research, it was established that the mechanisms of RDD formation are determined by the combined influence of clinical and genealogical, social and environmental (factors of mental trauma) and individual and psychological (stress resistance and personal characteristics) factors. Depending on the degree of severity of RDD, the specificity of the leading psychotraumatic factors is determined. Specific features of the syndromal structure of RDD depending on the severity of the course: with a mild depressive episode, anxiety-phobic and somatic-vegetative syndromes probably prevailed; with a moderate depressive episode — asthenic and apathetic syndromes; with a severe depressive episode — hypochondriac syndrome, asthenic and apathetic syndromes. It was established that a significant family accumulation of mental disorders in the pedigrees of patients with ADHD indicates a high role of hereditary factors in the occurrence of depressive disorders. According to the results of the study of individual and psychological features that determine the stress- protective qualities of the personality, it was determined that patients with RDD are characterized by: the presence of pronounced anti-vital tendencies (the most pronounced are “helplessness”, “negative image of the present and future”, “loneliness”, anxious ruminations, as well as anti-vital thoughts. Patients with RDD have a low level of vitality (resources to overcome obstacles and compensatory mechanisms). It was established that the frequency of genotypes associated with increased expression of P-glycoprotein (TT + ST genotypes) among patients is 68 %, and pharmacogenetically significant polymorphisms CYP2D6*4, CYP2C19*2 cause a high percentage of slow metabolizers (30 % and 23 % for markers CYP2D6*4 and CYP2C19*2, respectively), which indicates the importance of genetic testing for these markers before prescribing phar- macotherapy. It was found that the tendency of decreasing the frequency of genotypes associated with slow metabolism of antidepressants (CYP2D6*4, CYP2C19*2) and high expression of P-glycoprotein (MDR1) from severe to mild forms of depression may indicate the influence of these polymorphisms on the expressiveness of symptoms. The obtained data should be used for careful diagnosis of ADD, early detection of the risk of developing recurrent depression, selection of adequate pharmacotherapy taking into account genotyping and psycho- therapeutic measures.
Key words recurrent depression, formation, genealogical regularities, genetic regularities
Access to full text version of the article pdf download
Bibliography 1. Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Pat- ten SB, Vos T, Whiteford HA. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013 Mar;43(3):471-81. doi: 10.1017/S0033291712001511. 2. World Health Organization. Depression and Other Com- mon Mental Disorders. 2017. P. 1135—1999. URI: https://apps. who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER- 2017.2-eng.pdf.
3. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013 Nov;10(11):e1001547. doi: 10.1371/journal.pmed.1001547.
4. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, preva- lence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545- 1602. doi: 10.1016/S0140-6736(16)31678-6.
5. Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004 Feb;49(2):124-38. doi: 10.1177/070674370404900208.
6. Gaebel W, Becker T, Janssen B, Munk-Jorgensen P, Mu- salek M, Rössler W, Sommerlad K, Tansella M, Thornicroft G, Zielasek J; European Psychiatric Association. EPA guidance on the quality of mental health services. Eur Psychiatry. 2012 Feb;27(2):87-113. doi: 10.1016/j.eurpsy.2011.12.001.
7. Weissman MM, Bland RC, Canino GJ, Faravelli C, Gre- enwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lépine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickrama- ratne PJ, Wittchen H, Yeh EK. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996 Jul 24- 31;276(4):293-9. PMID: 8656541.
8. Lieb R, Isensee B, Höfler M, Pfister H, Wittchen HU. Pa- rental major depression and the risk of depression and other mental disorders in offspring: a prospective-longitudinal community study. Arch Gen Psychiatry. 2002 Apr;59(4):365-74. doi: 10.1001/archpsyc.59.4.365.
9. Brenner B, Cheng D, Clark S, Camargo CA Jr. Positive association between altitude and suicide in 2584 U.S. coun- ties. High Alt Med Biol. 2011 Spring;12(1):31-5. doi: 10.1089/ ham.2010.1058.
10. Andrews G, Henderson S, Hall W. Prevalence, comor- bidity, disability and service utilisation. Overview of the Aus- tralian National Mental Health Survey. Br J Psychiatry. 2001 Feb;178:145-53. doi: 10.1192/bjp.178.2.145.
11. Maruta, N. O., Zhupanova, D. O. Kliniko-psykholohichni osoblyvosti khvorykh na depresiiu z riznym rivnem medyka- mentoznoho komplaiensu (diahnostyka i korektsiia). Ukrainskyi visnyk psykhonevrolohii. 2016. T. 24, vyp. 1 (86). C. 5–11.
 12. Rakhman, L. V. Kontseptualni chynnyky rozvytku ta pryntsypy likuvannia terapevtychno rezys-tentnykh depresii. Ukrainskyi visnyk psykhonevrolohii. 2016. T. 24, No. 1 (86). S. 104–110.
13. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, La- bonté B, Szyf M, Turecki G, Meaney MJ. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009 Mar;12(3):342-8. doi: 10.1038/nn.2270.
14. Schatzberg AF, Keller J, Tennakoon L, Lembke A, Wil- liams G, Kraemer FB, Sarginson JE, Lazzeroni LC, Murphy GM. HPA axis genetic variation, cortisol and psychosis in major depression. Mol Psychiatry. 2014 Feb;19(2):220-7. doi: 10.1038/ mp.2013.129.
15. Liu Z, Zhu F, Wang G, Xiao Z, Wang H, Tang J, Wang X, Qiu D, Liu W, Cao Z, Li W. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major de- pression. Neurosci Lett. 2006 Sep 1;404(3):358-62. doi: 10.1016/j. neulet.2006.06.016.
 16. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depres- sion meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry. 2011 May;68(5):444-54. doi: 10.1001/ archgenpsychiatry.2010.189.
17. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000 Oct;157(10):1552-62. doi: 10.1176/appi.ajp.157.10.1552.
18. Ising M, Holsboer F. Genetics of stress response and stress-related disorders. Dialogues Clin Neurosci. 2006;8(4):433- 44. doi: 10.31887/DCNS.2006.8.4/mising.
19. Weissman MM, Berry OO, Warner V, Gameroff MJ, Skip- per J, Talati A, Pilowsky DJ, Wickramaratne P. A 30-Year Study of 3 Generations at High Risk and Low Risk for Depression. JAMA Psychiatry. 2016 Sep 1;73(9):970-7. doi: 10.1001/jama- psychiatry.2016.1586.
20. Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M. Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts. Neuropsychopharmacology. 2013 Jul;38(8):1504-11. doi: 10.1038/npp.2013.49.
21. Chen J, Li X, McGue M. The interacting effect of the BDNF Val66Met polymorphism and stressful life events on adolescent depression is not an artifact of gene-environment correlation: evidence from a longitudinal twin study. J Child Psychol Psychiatry. 2013 Oct;54(10):1066-73. doi: 10.1111/ jcpp.12099.
 22. Joëls M, Baram TZ. The neuro-symphony of stress. Nat Rev Neurosci. 2009 Jun;10(6):459-66. doi: 10.1038/nrn2632.
 23. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979 Apr;134:382-9. doi: 10.1192/bjp.134.4.382.
24. Titorenko, K. V. Genealogi ches koe drevo kak osnova zhiznesposobnosti sem'i i roda. Nauchno-metodicheskij e'lektronny'j zhurnal "Koncept". 2016. T. 11. S. 1631–1635.
25. Sagalakova O.A., Truevcev D.V. Oprosnik "Antivital'nost' i Zhiznestojkost'". Medicinskaya psixologiya v Rossii: e'lektronny'j nauchny'j zhurnal. 2017. T. 9, № 2 (43). C. 4. URL: http://mprj.ru. 26. Mnogourovnevy'j lichnostny'j oprosnik "Adaptivnost'" (MLO-AM) A. G. Maklakova i S. V. Chermyanina. Prakticheskaya psixodiagnostika. Metodiki i testy' : uchebnoe posobie / red. i sost. Rajgorodskij D. YA. Samara: Izdatel'skij Dom Baxrax-M, 2006. S. 549—672.
 27. Shherbaty'x YU. V. Psixologiya stressa i metody' korrekcii. SPb. : Piter, 2006. 256 s.
28. Fetiskin N.P., Kozlov V. V., Manujlov G. M. Social'no- psixologi ches kaya diagnostika razvitiya lichnosti i maly'x grupp. M. : Izd-vo Instituta psixoterapii, 2002. C.193—197.
29. Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol. 2003;17(1):27–41. 219. Daly AK. Pharmacogenetics of the major polymorphic me- tabolizing enzymes. Fundam Clin Pharmacol. 2003 Feb;17(1):27- 41. doi: 10.1046/j.1472-8206.2003.00119.x.
30. Lindpaintner K. Pharmacogenetics and pharmacoge- nomics in drug discovery and development: an overview. Clin Chem Lab Med. 2003 Apr;41(4):398-410. doi: 10.1515/ CCLM.2003.063.
31. Levkovych, N. M., Horovenko, N. H. Kharakterystyka henetychnoi struktury naselennia Ukrainy za polimorfnymy variantamy heniv systemy detoksykatsii ksenobiotykiv. Faktory eksperymentalnoi evoliutsii orhanizmiv : zb. nauk. pr. 2014.T. 14. S. 208—211.